Comprehensive Diagnostic & Therapeutic Reference Profile
Also known as: Factor VIII Deficiency (Hemophilia A), Factor IX Deficiency (Hemophilia B), Christmas Disease, Bleeder’s Disease, X-linked Coagulopathy.
Hemophilia is a group of inherited, X-linked recessive bleeding disorders characterized by a deficiency in essential clotting factors. The condition prevents the blood from clotting properly, leading to prolonged bleeding after injury, surgery, or spontaneous internal hemorrhage. Hemophilia A (classic) results from Factor VIII deficiency, while Hemophilia B (Christmas disease) results from Factor IX deficiency.
Hemophilia is primarily caused by mutations in the F8 (Factor VIII) or F9 (Factor IX) genes located on the X chromosome. Because it is X-linked, it predominantly affects males. Approximately 30% of cases occur due to spontaneous mutations in patients with no family history.
The coagulation cascade is impaired due to insufficient levels of clotting factors. This prevents the formation of the fibrin mesh necessary for stable clot stabilization. The pathophysiology manifests as persistent bleeding in soft tissues and joints (hemarthrosis), leading to chronic inflammation, synovial hypertrophy, and eventual joint destruction (hemophilic arthropathy).
Hemophilia A occurs in 1 in 5,000 live male births; Hemophilia B occurs in 1 in 25,0
A. Early Symptoms
A. Clinical Assessment: Family history, bleeding duration assessment.
B. Laboratory Testing: Coagulation profile.
C. Imaging Studies: Ultrasound/MRI for joint bleeds.
D. Functional Tests: Factor activity assays.
E. Biopsy Findings: Not indicated.
F. Genetic Testing: F8 or F9 gene sequencing.
G. Differential Diagnosis: Von Willebrand disease, Platelet function disorders.
Test Name: Activated Partial Thromboplastin Time (aPTT)
Type: Blood Test
Purpose: Screen for intrinsic pathway deficiency.
Expected Findings: Prolonged.
Interpretation: Indicates factor deficiency.
A. Lifestyle Modifications: Avoid contact sports.
B. Preventive Measures: Prophylactic factor replacement.
C. Medical Treatment: Recombinant Factor VIII/IX infusions.
D. Surgical Treatment: Orthopedic joint replacement.
E. Interventional Procedures: Synovectomy.
F. Rehabilitation: Physical therapy for range of motion.
G. Emergency Management: Rapid factor concentrate administration.
With modern prophylactic therapy, life expectancy is near-normal, though joint damage remains a major morbidity risk.
Genetic counseling and prenatal diagnosis for families with known mutations.
The following homeopathic remedies have been historically indicated for symptoms associated with Hemophilia Genetic. Selection should be based on individualized symptom totality and constitutional assessment.
This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.
Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Hemophilia Genetic.
Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, identify reference range variances, and generate a plain-English explanation of your disease risks.
Browse our full library of 200+ medical and pathology calculators.
📊 Browse All CalculatorsSpeak with our specialists for a customized treatment protocol for this condition.
📅 Request ConsultationThis clinical reference is for educational purposes only. It is not a substitute for professional medical diagnosis or treatment. Always consult a licensed healthcare practitioner.